Oxylabs lands first outside funding — $130M from Warburg Pincus at $3.6B valuation
What's the deal? OxylabsDealroom has a profile for this one. Try Dealroom →, a Lithuania-based data infrastructure platform, has raised $130 million in growth equity from Warburg Pincus, valuing the company at $3.6 billion. The investment came through the Warburg Pincus Capital Solutions Founders Fund and marks Oxylabs' first outside investment since its founding in 2015.
What does Oxylabs do? Founded in Vilnius, it began as a premium proxy service and now runs a full-stack web-data infrastructure platform serving over 350,000 customers. Its clients span the cybersecurity, e-commerce, and financial industries, including Fortune 500 companies.
What's the endgame? Oxylabs plans to use the capital to expand its global network, advance its technology, and build next-generation products. The company is positioning itself around AI agents that navigate the web at scale.
"The future belongs to the live infrastructure that grounds these systems in real-time, interruption free knowledge," said chief executive officer Vytautas Savickas.
Why now? The Warburg Pincus Capital Solutions Founders Fund closed in September 2024 with over $4 billion in commitments, with a flexible mandate to back founders through growth, M&A, or liquidity. Its principal Allison Ross said Oxylabs "has established itself as a leader in web intelligence through its sophisticated technology and expansive network."
The signal: At $130 million, the round sits in roughly the 30th percentile by size — a modest sum for a company valued at $3.6 billion. That gap reflects a bootstrapped operator taking outside capital for the first time to press its lead as AI agents reshape how the web gets read.
Read more: GlobeNewswire
